Prevention of myofilament dysfunction by β-blocker therapy in postinfarct remodeling

Circulation: Heart Failure

Volumn 2, Issue 3, 2009, Pages 233-242

  Duncker, Dirk J ^a   Boontje, Nicky M ^b   Merkus, Daphne ^a   Versteilen, Amanda ^b   Krysiak, Judith ^c   Mearini, Giulia ^d   El Armouche, Ali ^d   De Beer, Vincent J ^a   Lamers, Jos M J ^a   Carrier, Lucie ^d,e   Walker, Lori A ^f   Linke, Wolfgang A ^c   Stienen, Ger J M ^b   Van Der Velden, Jolanda ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e INSERM   (France)

^f UNIVERSITY OF COLORADO   (United States)

Author keywords

blockers; Contractility; Myocardial infarction; Myofilament proteins; Phosphatases

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; MYOSIN BINDING PROTEIN C; MYOSIN LIGHT CHAIN 2; PHOSPHOPROTEIN PHOSPHATASE 1; TROPONIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRESSLER SYNDROME; DRUG DOSE INCREASE; ENDOCARDIAL BIOPSY; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BISOPROLOL; CALCIUM SIGNALING; CARDIAC MYOSINS; CARRIER PROTEINS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICROFILAMENTS; MUSCLE PROTEINS; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; MYOSIN LIGHT CHAINS; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN PHOSPHATASE 1; PROTEIN PHOSPHATASE 2; RECOVERY OF FUNCTION; SWINE; TIME FACTORS; TROPONIN I; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 69549096469     PISSN: 19413289     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.108.806125     Document Type: Article

References (50)

1. Haitsma DB, Bac D, Raja N, Boomsma F, Verdouw PD, Duncker DJ. Minimal impairment of myocardial blood flow responses to exercise in the remodeled left ventricle early after myocardial infarction, despite significant hemodynamic and neurohumoral alterations. Cardiovasc Res. 2001; 52:417- 428.
2. Mudd JO, Kass DA. Reversing chronic remodeling in heart failure. Expert Rev Cardiovasc Ther. 2007; 5:585-598.
3. De Tombe PP. Altered contractile function in heart failure. Cardiovasc Res. 1998; 37:367-380.
4. Anand IS. Ventricular remodeling without cellular contractile dysfunction. J Card Fail. 2002; 8(6 Suppl):S401-S408.
5. Van der Velden J, Merkus D, Klarenbeek BR, James AT, Boontje NM, Dekkers DH, Stienen GJM, Lamers JM, Duncker DJ. Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction. Circ Res. 2004; 95:e85- e95.
6. Belin RJ, Sumandea MP, Kobayashi T, Walker LA, Rundell VL, Urboniene D, Yuzhakova M, Ruch SH, Geenen DL, Solaro RJ, de Tombe PP. Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure. Am J Physiol Heart Circ Physiol. 2006; 291:H2344-H2353.
7. Daniels MC, Naya T, Rundell VL, de Tombe PP. Development of contractile dysfunction in rat heart failure: hierarchy of cellular events. Am J Physiol Regul Integr Comp Physiol. 2007; 293:R284-R292.
8. De Waard MC, van der Velden J, Bito V, Ozdemir S, Biesmans L, Boontje NM, Dekkers DH, Schoonderwoerd K, Schuurbiers HC, de Crom R, Stienen GJ, Sipido KR, Lamers JM, Duncker DJ. Early exercise training normalizes myofilament function and attenuates left ventricular pump dysfunction in mice with a large myocardial infarction. Circ Res. 2007; 100:1079 -1088.
9. Bristow MR. β-adrenergic receptor blockade in chronic heart failure. Circulation. 2000; 101:558 -569.
10. Freemantle N, Cleland J, Young P, Mason J, Harrison J. Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999; 318:1730 -1737.
11. Kopecky SL. Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction. Am J Cardiol. 2006; 98:1115-1119.
12. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with betaadrenergic blockade. J Am Coll Cardiol. 1995; 25:1154 -1161.
13. Duncker DJ, Klassen CL, Ishibashi Y, Herrlinger SH, Pavek TJ, Bache RJ. Effect of temperature on myocardial infarction in swine. Am J Physiol. 1996; 270:H1189-H1199.
14. Näslund U, Häggmark S, Johansson G, Pennert K, Reiz S, Marklund SL. Effects of reperfusion and superoxide dismutase on myocardial infarct size in a closed chest pig model. Cardiovasc Res. 1992; 26: 170 -178.
15. Lee-de Groot MB, Tombe AL, van der Laarse WJ. Calibrated histochemistry of myoglobin concentration in cardiomyocytes. J Histochem Cytochem. 1998; 46:1077-1084.
16. Borbely A, van der Velden J, Papp Z, Bronzwaer JG, Edes I, Stienen GJM, Paulus WJ. Cardiomyocyte stiffness in diastolic heart failure. Circulation. 2005; 111:774 -781.
17. Zaremba R, Merkus D, Lamers JMJ, Paulus WJ, dos Remedios C, Duncker DJ, Stienen GJM, van der Velden J. Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies. Proteomics Clin Appl. 2007; 1:1285-1290.
18. Yuan C, Guo Y, Ravi R, Przyklenk K, Shilkofski N, Diez R, et al. Myosin binding protein C is differentially phosphorylated upon myocardial stunning in canine and rat hearts. Evidence for novel phosphorylation sites. Proteomics. 2006; 6:4176-4186.
19. Neagoe C, Kulke M, del Monte F, Gwathmey JK, de Tombe PP, Hajjar RJ, Linke WA. Titin isoform switch in ischemic human heart disease. Circulation. 2002; 106:1333-1341.
20. McClellan G, Kulikovskaya I, Winegrad S. Changes in cardiac contractility related to calcium-mediated changes in phosphorylation of myosinbinding protein C. Biophys J. 2001; 81:1083-1092.
21. Belin RJ, Sumandea MP, Allen EJ, Schoenfelt K, Wang H, John Solaro R, de Tombe PP. Augmented protein kinase C-α-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure. Circ Res. 2007; 101:195-204.
22. Feng J, Schaus BJ, Fallavollita JA, Lee TC, Canty JM. Preload induces troponin I degradation independently of myocardial ischemia. Circulation. 2001; 103:2035-2037.
23. Narolska NA, Piroddi N, Belus A, Boontje NM, Scellini B, Deppermann S, Zaremba R, Musters RJ, dos Remedios C, Jaquet K, Foster DB, Murphy AM, van Eyk JE, Tesi C, Poggesi C, van der Velden J, Stienen GJM. Impaired diastolic function after exchange of endogenous troponin I with C-terminal truncated troponin I in human cardiac muscle. Circ Res. 2006; 99:1012-1020.
24. Solaro RJ, Moir AJ, Perry SV. Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart. Nature. 1976; 262:615- 617.
25. Yamasaki R, Wu Y, McNabb M, Greaser M, Labeit S, Granzier H. Protein kinase A phosphorylates titin's cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes. Circ Res. 2002; 90: 1181-1188.
26. El-Armouche A, Pohlman L, Schlossarek S, Starbatty J, Yeh Y, Nattel S, Dobrev D, Eschenhagen T, Carrier L. Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure. J Mol Cell Cardiol. 2007; 42:223-229.
27. Hamdani N, Kooij V, van Dijk S, Merkus D, Paulus WJ, dos Remedios C, Duncker DJ, Stienen GJM, van der Velden J. Sarcomeric dysfunction in heart failure. Cardiovasc Res. 2008; 77:649-658.
28. Gautel M, Zuffardi O, Freiburg A, Labeit S. Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction? EMBO J. 1995; 14:1952-1960.
29. Bowling N, Walsh RA, Song G, Estridge T, Sandusky GE, Fouts RL, Mintze K, Pickard T, Roden R, Bristow MR, Sabbah HN, Mizrahi JL, Gromo G, King GL, Vlahos CJ. Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation. 1999; 99:384 -391.
30. Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, Kimball TF, Lorenz JN, Nairn AC, Liggett SB, Bodi I, Wang S, Schwartz A, Lakatta EG, DePaoli-Roach AA, Robbins J, Hewett TE, Bibb JA, Westfall MV, Kranias EG, Molkentin JD. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nature. 2004; 10: 248-254.
31. Jideama NM, Noland TA Jr, Raynor RL, Blobe GC, Fabbro D, Kazanietz MG, Blumberg PM, Hannun YA, Kuo JF. Phosphorylation specificities of protein kinase C isozymes for bovine cardiac troponin I and troponin T and sites within these proteins and regulation of myofilament properties. J Biol Chem. 1996; 271:23277-23283.
32. Burkart EM, Sumandea MP, Kobayashi T, Nili M, Martin AF, Homsher E, Solaro RJ. Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity. J Biol Chem. 2003; 278:11265-11272.
33. Sumandea MP, Pyle WG, Kobayashi T, de Tombe PP, Solaro RJ. Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J Biol Chem. 2003; 278:35135-35144.
34. Neumann J. Altered phosphatase activity in heart failure, influence on Ca2+ movement. Basic Res in Cardiol. 2002; 97:I91-195.
35. Zhang R, Zhao J, Mandveno A, Potter JD. Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. Circ Res. 1995; 76:1028 -1035.
36. Kentish JC, McCloskey DT, Layland J, Palmer S, Leiden JM, Martin AF, Solaro RJ. Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle. Circ Res. 2001; 88:1059 -1065.
37. Cazorla O, Szilagyi S, Vignier N, Salazar G, Krämer E, Vassort G, Carrier L, Lacampagne A. Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. Cardiovasc Res. 2006; 69:370 -380.
38. Van der Velden J, Papp Z, Zaremba R, Boontje NM, de Jong JW, Owen VJ, Burton PBJ, Goldmann P, Jaquet K, Stienen GJM. Increased Ca2- sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. Cardiovasc Res. 2003; 57:37- 47.
39. Messer AE, Jacques AM, Marston SB. Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. J Mol Cell Cardiol. 2007; 42:247-259.
40. Fukuda N, Wu Y, Nair P, Granzier HL. Phosphorylation of titin modulates passive stiffness of cardiac muscle in a titin isoform-dependent manner. J Gen Physiol. 2005; 125:257-271.
41. Linke WA. Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction. Cardiovasc Res. 2008; 77:637- 648.
42. Mou YA, Reboul C, Andre L, Lacampagne A, Cazorla O. Late exercise training improves non-uniformity of transmural myocardial function in rats with ischaemic heart failure. Cardiovasc Res. 2009; 81:555-564.
43. El-Armouche A, Bednorz A, Pamminger T, Ditz D, Didié M, Dobrev D, Eschenhagen T. Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes. Biochem Biophys Res Commun. 2006; 346:700 -706.
44. Neumann J, Gupta RC, Schmitz W, Scholz H, Nairn AC, Watanabe AM. Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor- 1 in the intact heart. Circ Res. 1991; 69:1450 -1457.
45. Carr AN, Schmidt AG, Suzuki Y, del Monte F, Sato Y, Lanner C, Breeden K, Jing SL, Allen PB, Greengard P, Yatani A, Hoit BD, Grupp IL, Hajjar RJ, DePaoli-Roach AA, Kranias EG. Type I phosphatase, a negative regulator of cardiac function. Mol Cell Biol. 2002; 22: 4124-4135.
46. El-Armouche A, Rau T, Zolk O, Ditz D, Pamminger T, Zimmermann WH, Jäckel E, Harding SE, Boknik P, Neumann J, Eschenhagen T. Evidence for protein phosphatase inhibitor-1 playing an amplifier role in β-adrenergic signaling in cardiac myocytes. FASEB J. 2003; 17:437- 439.
47. Duncker DJ, Haitsma DB, Liem DA, Verdouw PD, Merkus D. Exercise unmasks autonomic dysfunction in swine with a recent myocardial infarction. Cardiovasc Res. 2005; 65:889-896.
48. Duncker DJ, de Beer V, Merkus D. Alterations in vasomotor control of coronary resistance vessels in remodelled myocardium of swine with a recent myocardial infarction. Med Biol Eng Comput. 2008; 46: 485- 497.
49. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. CIBIS-II Investigators and Committees. Lancet. 1999; 353:9 -13.
50. Doughty RN, Whalley GA, Walsh HA, Gamble GD, López-Sendón J, Sharpe N; CAPRICORN Echo Substudy Investigators. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation. 2004; 109: 201-206.